Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the long-term remission rate of short-term intensive insulin (STII) therapy in
newly diagnosed type 2 diabetes outpatients and investigate the predictors contributing to
the remission rate.